C

Celltrion Pharm Inc
KOSDAQ:068760

Watchlist Manager
Celltrion Pharm Inc
KOSDAQ:068760
Watchlist
Price: 53 000 KRW 0.76% Market Closed
Market Cap: 2.2T KRW
Have any thoughts about
Celltrion Pharm Inc?
Write Note

Net Margin
Celltrion Pharm Inc

3.8%
Current
7%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
3.8%
=
Net Income
16.5B
/
Revenue
437.4B

Net Margin Across Competitors

Country KR
Market Cap 2.2T KRW
Net Margin
4%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 744.2B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.3T DKK
Net Margin
35%
Country US
Market Cap 373.9B USD
Net Margin
17%
Country US
Market Cap 258.4B USD
Net Margin
19%
Country CH
Market Cap 200.6B CHF
Net Margin
20%
Country UK
Market Cap 161.8B GBP
Net Margin
13%
Country CH
Market Cap 180.7B CHF
Net Margin
35%
Country US
Market Cap 146.9B USD
Net Margin
7%
No Stocks Found

Celltrion Pharm Inc
Glance View

Market Cap
2.2T KRW
Industry
Pharmaceuticals

Celltrion Pharm, Inc. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Cheongju, Chungcheongbuk-Do and currently employs 841 full-time employees. The company went IPO on 2006-02-03. The Company’s products include hepatotonics, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs, circularly system drugs, digestives and stomachic drugs, hormone disease drugs, antibiotics, nutrients, tonics, and other drugs. The company also provides ethical drugs and over-the-counter (OTC) drugs. The firm distributes its products in domestic market and overseas markets such as Philippines, Kazakhstan, Cambodia and other Southeast Asia countries.

Intrinsic Value
17 592.39 KRW
Overvaluation 67%
Intrinsic Value
Price
C

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
3.8%
=
Net Income
16.5B
/
Revenue
437.4B
What is the Net Margin of Celltrion Pharm Inc?

Based on Celltrion Pharm Inc's most recent financial statements, the company has Net Margin of 3.8%.